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Probiotics such as Lactobacillus and Bifidobacterium have been successfully used to 
promote growth and prevent diseases. Previous reports have demonstrated that Bacillus 
subtilis (B. subtilis) was a potential probiotic for animals. In this research, 180 B. sub-
tilis were isolated from the soil, identified, and investigated in  vitro. Furthermore, five 
B. subtilis were selected and mixed to investigate their effect on growth performance, 
immune response, intestine microbiota, and disease resistance in rabbits. Rabbits with 
a diet of 106  CFU  g−1 mixed B. subtilis exhibited the best growth performance and 
higher serum IgG and IgA than controls (P < 0.05). Moreover, dairy with B. subtilis can 
promote the balance of intestinal flora. The major proinflammatory factor and β-defensin 
were upregulated compared with the controls. After 7 weeks of feeding, the survival 
rate of the rabbits fed with B. subtilis was significantly higher than those in the control 
groups postinfected with Escherichia coli. At the same time, this study detected higher 
expression of β-defensin and reduced bacteria contents of the heart and cecal contents 
from the diet mixed with B. subtilis compared with the control groups. In conclusion, 
dietary supplementation with B. subtilis for rabbits could improve growth performance, 
intestinal homeostasis, and immune organ index and enhance innate immune response 
as well as disease resistance. These findings showed that the induction of β-defensin by 
B. subtilis might be an interesting new therapeutic strategy to strengthen innate defense 
mechanisms.
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inTrODUcTiOn
Antibiotics used in animal breeding introduce problems while improving growth performance (1). 
The administration of antibiotics, whether therapeutically or prophylactically, disturbs the normal 
microbiotic balance of the host (2). Consequently, an awareness of antimicrobial-resistant micro-
organisms caused by antibiotics encourages the development of probiotics (3). Probiotics are a safe 
alternative to antibiotics and are supplemented in the diet to prevent diseases and promote growth. 
Due to the spore’s resistance, survival in extreme environments, and long-term storage, spore-
forming Bacillus spp. are considered to be suitable probiotics (4). They not only produce certain 
essential nutrients, such as amino acids, and vitamins K and B12 to promote growth performance (5) 
but they also promote the proliferation of beneficial anaerobic bacteria by consuming the free oxygen 
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in the intestinal tract (6). In a previous study, Bacillus subtilis (B. 
subtilis) DJM-51 isolated from soil demonstrated strong antago-
nism toward the tomato pathogen Clavibacter michiganense 
subsp. michiganense ATCC 7429 (7).
According to guidelines for evaluating probiotics in food 
reported by a joint UN Food and Agricultural Organization 
World Health Organization working group, resistance to gastric 
acidity and bile salts are two of the most widely used in  vitro 
tests based on both survival and growth studies. Furthermore, 
given serious concerns about increased resistance to antibiotics 
due to their regular use as additives, one aspect of probiotics that 
needs to be analyzed is antibiotic resistance. Probiotic strains, as 
well as bacteria used in food, can harbor resistant genes that can 
be transferred to pathogenic bacteria (8). As a result, probiotic 
strains intended for meat animals should be screened for antibi-
otic resistance (9).
The advantages of probiotics on hosts range from improved 
metabolism, immunostimulation, and anti-inflammatory status 
to the elimination of pathogens. Innate immunity is the first line 
of defense against the colonization of pathogens, and it plays a 
critical role in the pathogenesis and progression of intestinal dis-
orders. The current findings confirmed that probiotics promote 
gut health through stimulation of the innate immune system in 
chronic Crohn’s disease-like ileitis mouse model (10). Recently, 
it was reported that dietary B. subtilis reduced clinical signs of 
enteric diseases, such as Salmonella, or clostridial diseases, such 
as necrotic enteritis, which correlated with increased innate 
immunity in broiler chickens (11, 12).
Several bacterial diseases afflict the rabbit breeding industry, 
including pathogenic Escherichia coli (E. coli) infection and rabbit 
Clostridium perfringens disease (13, 14). Treatment for the dis-
eases cannot involve the use of long-term antibiotics due to their 
negative effects. For example, antibiotic-associated diarrhea is 
caused by Clostridium or Staphylococcus aureus (15). Probiotics, 
including potentially beneficial bacteria, enter the guts of humans 
and other animals, where their beneficial qualities improve intes-
tinal balance, modulate and stimulate immune function, produce 
inhibitory compounds, and compete for chemicals and adhesion 
sites (16, 17). Many studies involving both pig and poultry diets 
with B. subtilis led to a reduction of Clostridium and Coliforms 
in host guts (18, 19). As an alternative, probiotics have shown 
considerable promise in promoting the health and performance 
of rabbits (20, 21).
In response, to identify potential candidate probiotics for rab-
bits, this study separated B. subtilis strains from the soil, screened 
for the strain with the best performance in an in vitro probiotic 
potential evaluation, and assessed that strain’s effects on weaning 
rabbits in a practical assessment.
MaTerials anD MeThODs
B. subtilis and Pathogen
Soil samples were collected at a depth of 10 cm under the earth’s 
surface from Mount Tai, which is located in Tai’an city in the 
Shandong Province of China. First, 10 g of soil were suspended 
in 100 mL of sterile water in a conical flask. After incubation at 
80°C for 1 h, the culture was diluted and spread on modified agar 
plates (glucose 5 g, yeast extract 5 g, peptone 5 g, beef paste 5 g, 
NaCl 5 g, and agar powder 20 g in 1 L of sterilized water with pH 
7.0–7.2) and incubated at 37°C for 24–72 h. Suspected colonies 
were subjected to Gram stain and biochemical tests, including an 
arabinose biochemical tube test, glucose biochemical tube test, 
mannitol biochemical tube test, 3% NaCl gelatin biochemical 
tube test, and MR-VP biochemical tube test. Following those 
tests, 16S rRNA sequencing was performed with universal prim-
ers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R 
(5′-GGTTACCTTGTTACGACTT-3′), and the sequences were 
blasted in NCBI.
The bacterial pathogen, enterohemorrhagic E. coli, was 
previously isolated from clinically infected rabbits developing 
acute diarrhea and stored by the Environmental Microbiology 
Laboratory at Shandong Agricultural University.
screening for Probiotic Properties  
In Vitro
Artificial Gastric Juice, Intestinal Juice, and Bile Salt 
Tolerance
This study was designed as in a model gastrointestinal tract 
experiment to investigate the survival of B. subtilis. Overnight 
cultures of B. subtilis were centrifuged at 3,000 × g for 10 min, 
washed twice with phosphate buffer saline, and resuspended 
in a new liquid medium (108 CFU mL−1). The new media were 
adjusted to pH 2.5 by adding a hydrochloric acid solution with 
1% pepsin or to pH 7.2 with 1% trypsin and incubated at 37°C. At 
0, 1, and 2 h of incubation, 100 μL of the cultures were removed 
and spread on modified nutrition agar for cell number estima-
tion. Respectively, the bacterial suspensions were inoculated into 
modified nutrition broth with 0.3% bile salt and cultured at 37°C 
for 24 h. Optical density at 600 nm (OD600) was measured and 
compared to a control culture without bile salts.
Protease Assay
These isolates were screened for neutral and alkaline protease 
production. Overnight cultures of B. subtilis strains were cen-
trifuged at 6,000 × g for 15 min, and then the supernatant was 
assayed for protease activity according the SB/T 10317-1999 (22).
Antimicrobial Activities
The well diffusion method was performed on agar using cultured 
broth. Briefly, the target strain (106 CFU mL−1) was incorporated 
into agar (1% w/v) plates, which were mixed for uniformity and 
poured onto plates to solidify. Overnight cultures of B. subtilis 
(108  CFU  mL−1) were transferred to holes (5-mm diameter) 
punched into the agar palates. The plates were then incubated 
as anaerobic or aerobic at 37°C for 24 h, depending on the target 
strain, and the antimicrobial ability was recorded as being in the 
inhibition zone (23).
Antibiotic Susceptibility
Bacillus subtilis suspensions were spread on Muller–Hinton agar 
plates, onto which antibiotic disks of penicillin, kanamycin, 
doxycycline, tetracycline, gentamicin, lincomycin, erythromycin, 
cefotaxime, and streptomycin were placed. After 24 h incubation 
at 37°C, the inhibition zone was measured (24).
Table 1 | composition and nutrient levels of the experimental diet (air-
dry basis).
ingredients content  
(%)
composition content
Soybean meal 5.00 CP (%) 16.04
Wheat bran 16.00 EE (%) 3.34
Alfalfa meal 6.00 CF (%) 16.73
Sunflower meal 9.00 Digestible energy (MJ/kg)b 10.32
Corn germ meal 24.00 Ca (%) 0.92
Corn 10.00 P (%) 0.42
Rice husk 6.00 Lys (%) 0.49
Soybean phospholipids 3.00 Met (%) 0.18
Barley husk 10.00
Haulm powder 9.00
Limestone 1.00
Premixa 1.00
Total 100
aPremix provided the following per kilogram of diets: VA, 8,000 IU; VD, 31,000 IU; VE, 
50 mg; Lys, 1.5 g; Met, 1.5 g; Cu, 50 mg; Fe, 100 mg; Mn, 30 mg; Mg, 150 mg; I, 
0.1 mg; Se, 0.1 mg.
bCalculated values.
Table 2 | Primers used in this study.
Primer name sequence(5′-3′) Product 
size (bp)
genbank no.
NOD1 F acaaggttcgcaaaatcctg 169 XM008261590.2
NOD1 R ttgacaatggctttgctctg
NOD2 F caacctcaagggcttctcag 241 XM008275042.2
NOD2 R caggaaatgctgcaagatca
NLRC3 F acatcatccgaggcaatctc 168 XM017338739.1
NLRC3 R tctggtcctcagggaacatc
NLRX1 F gtttcgggaggaggactacc 204 XM017338655.1
NLRX1 R tccatgttcttgatgggaca
IL-1β F tggcacgtatgagctgaaag 115 NM001082201.1
IL-1β R ggccacaggtatcttgtcgt
IL-4 F cactccggcagttctacctc 104 NM001163177.1
IL-4 R gcagaggttcctgtcgagtc
IL-8 F ctctcttggcaaccttcctg 165 KT216053.1
IL-8 R ttgcacagtgaggtccactc
IL-10 F aaaagctaaaagccccagga 143 NM001082045.1
IL-10 R cgggagctgaggtatcagag
IFN-γ F ctcgaatttcggtggatgat 118 DQ680162.1
IFN-γ R agcgtctgactcctttttcg
PKR F attggccattcatcatggtt 162 XM008258792.2
PKR R ttctcggcagcatttctctt
OAS F gagctcctgaccatctacgc 182 XM002722126.3
OAS R gccttgagctgtttcctgac
DEFB114 F taccagccacatgctctttg 134 XM017344866.1
DEFB114 R cctgtcgacacagcaaatct
DEFB124 F gcaccaagcaagagtccttc 117 XM017342171.1
DEFB124 R acgccagagccagctactta
DEFB125 F cgtgctgcatctccttaaca 114 XM008256168.2
DEFB125 R gcgaagcagaaaattgatcc
DEFB127 F cccacagtaaccgagcaact 126 XM002710854.1
DEFB127 R gctgaggcagcagtatctcc
DEFB128 F gggctcaaggctttctcttt 200 XM017342173.1
DEFB128 R aaatctcgcctagcttgcac
DEFB134 F agcctgtctgcctggagtag 156 XM017337690.1
DEFB134 R gatgaggagaggcttcatgg
DEFB135 F gctgcatctccaaatccaat 116 XM017337693.1
DEFB155 R tagtgggatggtgcaactga
NP 5 F aggcaggcgtgttctgtact 154 M64602.1
NP 5 R ggtctccacgcaaataagga
Glyceraldehyde-
3-phosphate 
dehydrogenase 
(GAPDH) F
aggtcatccacgaccacttc 202 NM001082253.1
GAPDH R gtgagtttcccgttcagctc
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animals and cells
The healthy weaned New Zealand White rabbits (35 days) were 
kept in the same environment with sufficient room, feed, and 
ventilation. The rabbits were fed with a basal diet supplemented 
with 0, 105, 106, and 107 CFU g−1 B. subtilis cells (mixture of BYS2, 
BQ3, BD17, BG5, and BGY12). The formula of the basic diet 
for each group is shown in Table  1. The rabbits were handled 
in accordance with the appropriate biosecurity guidelines, and 
all experimental protocols were approved by the Shandong 
Agricultural University Animal Care and Use Committee (no. 
SDAUA-2015-005).
Rabbit kidney (RK-13) cells were grown in DMEM (GIBCO, 
Grand Island, USA) containing 10% fetal bovine serum (Transgen, 
Beijing, China) at 37°C in 5% CO2.
16s rrna gene sequencing and analysis
The cecal contents bacterial DNA of each sample was extracted 
using HiPure Stool DNA Kit B (Magen, Shanghai, China) fol-
lowing the manufacturer’s instructions. The DNA extractions 
were quantified by ultraviolet spectroscopy and amplified using 
universal primers of 341F (CCTACGGGNGGCWGCAG) 
and 806R (GGACTACHVGGGTATCTAAT) to target the 
V3–V4 domain of bacterial 16S rRNA. The amplicons were 
normalized, pooled, and sequenced on the Illumina GAIIx 
platform.
The raw Illumina fastq files were quality-filtered, de-multi-
plexed, and analyzed using quantitative insights into microbial 
ecology. Sequences with more than one ambiguous nucleotide or 
within correct barcodes or primers were removed. The Ribosomal 
Database Project classifier was used to classify tags into different 
taxonomies against Greengenes Database (version 20101006) 
with confidence threshold of 0.5. The software Mothur was 
used to cluster tags of more than 97% identity into operational 
taxonomic units (OTUs), and then the abundances of OTUs were 
calculated.
Quantitative real-time rT-Pcr
Total RNA was extracted from the spleen and jejunum of rabbits 
using TransZol Up (Transgen, Beijing, China), and 1  µg total 
RNA was reverse-transcribed with HiScript® II Q Select RT 
SuperMix for qPCR (+gDNA wiper) (Vazyme, Nanjing, China). 
Quantitative real-time PCR (qRT-PCR) oligonucleotide prim-
ers for immune-related genes and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were designed using Primer 3 software 
(http://bioinfo.ut.ee/primer3-0.4.0/), based on the published 
GenBank sequence (Table  2). qRT-PCR was performed using 
FigUre 1 | antibacterial activity of Bacillus subtilis against four pathogenic bacteria (Enteropathogenic Escherichia coli cVcc 1512, Salmonella 
cMcc 50094, Staphylococcus aureus aTcc 25923, and Clostridium perfringens ncTc 528). Bars represented the means ± SDs of three independent 
repetitions.
Table 4 | neutral and alkaline protease production of Bacillus subtilis.
bYs2 bQ3 bD17 bgY12 bg5 B. subtilis cMcc63501
Neutral protease (U mL−1) 1.3 ± 0.6 0 0 50.2 ± 3.8 60.7 ± 5.7 4.6 ± 1.3
Alkaline protease (U mL−1) 4.3 ± 1.6 2.3 ± 1.5 3.4 ± 0.9 48.6 ± 3.2 42.3 ± 5.1 2.5 ± 0.7
Values were expressed as means ± SDs of three independent repetitions.
Table 3 | survival rate of Bacillus subtilis at artificial gastric juice, 
intestinal juice, and bile (%).
strains 1 h 2 h bile
gastric 
juice
intestinal 
juice
gastric 
juice
intestinal 
juice
BYS2 100 100 100 100 47 ± 2.8
BQ3 100 100 100 100 49 ± 3.3
BGY12 100 100 100 100 100
BD17 81 ± 9.2 100 73 ± 4.3 100 48 ± 4.7
BG5 78 ± 4.3 100 82 ± 5.2 100 65 ± 4.0
B. subtilis 
CMCC63501
41 ± 3.1 100 17 ± 0.7 100 38 ± 1.8
Values were expressed as means ± SDs of three independent repetitions.
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TransStart Tip Green qPCR SuperMix (Transgen Biotech Co., 
Ltd., Beijing, China) and the Applied Biosystems 7500 Fast 
Real-Time PCR System (Applied Biosystems, CA, USA). The 
qRT-PCR conducted in a total volume of 20 µL and the amplifica-
tion steps consisted of 94°C for 30 s, 40 cycles of denaturation 
at 94°C for 5 s, and extension 60°C for 34 s, and a dissociation 
curve analysis. The purified PCR products were cloned into the 
pMD18-T and sequenced to verify correct amplification. Each 
sample was performed in triplicate. Data were calculated based 
on the 2−ΔΔCt method. The relative expression mRNA was nor-
malized to GAPDH.
statistical analysis
Statistical analyses were performed with SPSS 19.0, and one-way 
analysis of variance was used to identify differences among the 
groups. When variances were not homogeneous, the data were 
analyzed by the non-parametric Mann–Whitney U test or the 
Kruskal–Wallis test. The survival rate of rabbits was analyzed 
using the Kaplan–Meier method. Statistically significant differ-
ences required that P < 0.05.
resUlTs
Probiotic Potential evaluation of B. subtilis 
In Vitro
According to colony morphology and the results of microscopic 
examination, Gram-positive Bacillus strains with the typical 
volcano shape were selected as subjects for biochemical experi-
ments. In total, 180 B. subtilis were isolated from the soil and 
confirmed by 16S rRNA sequencing. Five strains (BYS2, BQ3, 
BD17, BG5, and BGY12) exhibited excellent probiotic properties 
in vitro, including artificial gastric juice, intestinal juice, and bile 
salt tolerance (Table 3). BG5 and BGY12 had good performance 
in protease activities (Table  4). BYS2, BQ3, and BD17 showed 
good antimicrobial activities (Figure 1). All five B. subtilis were 
susceptible to the common antibiotics tested (data not shown). 
The 16S rRNA sequence of five B. subtilis was deposited in 
GenBank (Genbank no. KY750231-235).
FigUre 2 | effects of dietary supplementation with Bacillus subtilis on growth performance and serum immunoglobulin in rabbits. (a) The rabbits’ 
individual body weights were measured during feeding weeks 4–7. Bars were expressed as means ± SDs of three independent experiments (20 rabbits per 
experiment). One-way analysis of variance was conducted to examine differences. *P < 0.05. The blood samples were collected during feeding weeks 4–7. The 
concentrations of IgA (b), IgG (c), and IgM (D) are represented. Bars represented the means ± SDs of three independent experiments (five rabbits per experiment). 
Kruskal–Wallis test was conducted to examine differences. *P < 0.05.
FigUre 3 | effects of dietary supplementation with Bacillus. subtilis 
on immune organ index in rabbits. The thymus and spleen were weighed 
to calculate the immune organ index. Bars represented the means ± SDs of 
three independent experiments (five rabbits per experiment). Mann–Whitney 
U test was conducted to examine differences. *P < 0.05.
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growth Performance and serum 
immunoglobulin
After 4, 5, 6, and 7 weeks of feeding, rabbits fed with the diet 
of 106 CFU g−1 B. subtilis showed the best growth performance 
and were heavier (P  <  0.05) than the control diet rabbits. 
Rabbits fed a diet with 107 CFU g−1 B. subtilis showed higher 
growth performance than the controls, but the difference was 
not significant (P > 0.05). However, no significant differences 
were observed between rabbits fed with 105 CFU g−1 B. subtilis 
diets and the controls after 4, 5, 6, and 7  weeks of feeding 
(Figure 2A). After 4, 5, 6, and 7 weeks of feeding, rabbits fed 
with the diet of 106 CFU g−1 B. subtilis had higher (P < 0.05) 
serum IgG and IgA than the controls. However, the serum IgA 
of rabbits fed with 107  CFU  g−1 B. subtilis were significantly 
different (P < 0.05) than the controls after only 5 and 6 weeks 
of feeding (Figures  2B,C). Consistent with the growth per-
formance results, the serum immunoglobulin of rabbits fed 
105  CFU  g−1 B. subtilis were virtually unchanged, especially 
IgM (Figure 2D). Based on these results research above, rabbits 
fed with the diet of 106 CFU g−1 B. subtilis were chosen for the 
following assays.
immune Organ index
As shown in Figure  3, the relative weights of the thymus and 
spleen were significantly increased by diet with B. subtilis after 
5 weeks of feeding. However, there was no difference between the 
group supplemented with B. subtilis and the controls after 7 weeks 
of feeding.
Taxonomic composition of intestine 
Microbiota
High-throughput sequence analysis of bacterial 16S rRNA V3–
V4 region was conducted on cecal contents of rabbits after 5 
and 7 weeks of feeding. As shown in Figure 4A, the 95.0–96.5% 
FigUre 4 | comparison of identified bacteria relative abundance in cecal contents. The cecal contents of rabbits fed with 106 CFU g−1 Bacillus subtilis diets 
and the controls were collected for high-throughput sequence analysis after 5 and 7 weeks of feeding. (a) Relative abundance at the phylum level. (b) Relative 
abundance at the genus level. (c) Relative abundance of three genera Ruminococcus, (D) Bacteroides, and (e) Clostridium. Bars were expressed as means ± SDs 
(n = 3). C5W, A5W, and A7W represented sample of control, active at 5 weeks, and active at 7 weeks of feeding, respectively. Kruskal–Wallis test was conducted to 
examine differences. *P < 0.05.
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reads belong to Firmicutes, Bacteroidetes, Verrucomicrobia, 
and Proteobacteria at the phylum level. The relative abundance 
of the phyla Firmicutes was increased after feeding B. subtilis. 
The shifts in bacterial composition at the phylum level were 
caused by the changes at the genus level (Figure 4B). In par-
ticular, the relative abundance of Ruminococcus (Figure  4C; 
P < 0.05) was increased after 5 weeks of feeding. The percent-
age of Bacteroides (Figure  4D; P  <  0.05) and Clostridium 
(Figure 4E; P < 0.05) were significantly decreased after 5 and 
7 weeks of feeding.
expression of innate immune-related 
genes In Vivo and In Vitro
To determine the induction of innate immunity in rabbits fed 
with a diet of B. subtilis, the expressions of innate immune-related 
genes were examined in the spleen and jejunum of rabbits fed 
with the probiotic compared to the controls after 5 and 7 weeks 
of feeding. Figure 5A shows that expressions of nucleotide oli-
gomerization domain (NOD) 1 were upregulated in the spleen 
and jejunum. After 5 weeks of feeding, it was upregulated by 2.48-
fold in the spleen (P < 0.05). The expression of NOD-like receptor 
(NLR) C3 and NLRX1 was generally higher in the jejunum than 
in the spleen (Figures  5C,D). For example, the expression of 
NLRC3 was elevated by 3.74-fold in the jejunum after 7 weeks 
of feeding (P < 0.05; Figure 5C), which is 2 times higher than 
that in the spleen. However, the NOD 2 expression was not obvi-
ously changed (Figure 5B). The expression of proinflammatory 
cytokines (IL-1β and IL-8) was upregulated in the spleen and 
jejunum (Figures  5F,H), while anti-inflammatory cytokines 
(IL-4 and IL-10) showed slight variation (Figures  5G,I). In 
particular, the expression of IL-8 was upregulated by 10.46- and 
5.73-fold in the spleen after 5 and 7 weeks of feeding (P < 0.05; 
Figure 5H). Figure 5E shows that the expression of IFN-γ was 
upregulated by 2.46-fold (P < 0.05) in the jejunum after 7 weeks 
of feeding. The antiviral proteins OAS showed no significant 
difference (P > 0.05; Figure 5J), whereas the expression of PKR 
in jejunum was upregulated by 7.45-fold after 5 weeks of feed-
ing (P < 0.05; Figure 5K). When the expressions of β-defensin 
(DEFB 114, DEFB 124, DEFB 125, DEFB 127, DEFB 128, DEFB 
134, and DEFB 135) and α-defensin (NP 5) were investigated, 
all of these genes showed elevated expression in the spleen and 
jejunum after 7  weeks of feeding. The expressions of DEFB 
114 and DEFB 134 were upregulated by two fold to three fold 
in the spleen and jejunum (P < 0.05; Figures 5L,Q). Moreover, 
the expressions of DEFB 124, DEFB 127, and DEFB 134 were 
upregulated in the spleen and jejunum after 5 weeks of feeding 
(P < 0.05; Figures 5M,O,Q). However, the expression of DEFB 
125, DEFB 128, DEFB 135, and NP 5 showed no significant dif-
ference (P > 0.05; Figures 5N,P,R,S).
To further explore the induction of innate immunity by B. 
subtilis, the RK-13 cell were stimulated by live B. subtilis and 
killed cells. The expressions of IL-1β and IL-8 were upregulated 
by 18.6- and 17.2-fold, respectively, after stimulation with live 
B. subtilis (P < 0.05; Figure 6), which were significantly higher 
than stimulation with killed cells. Similarly, the expression of 
DEFB127, DEFB 128, and DEFB 134 upregulated by 2.5-, 2.6-, 
and 2.3-fold, respectively, after stimulation with live B. subtilis 
(P < 0.05), which were not obviously changed after stimulation 
with killed cells.
survival rate
The survival rate of rabbits fed B. subtilis was significantly higher 
than the controls after the E. coli challenge. At 1, 2, and 3 days 
postinfection (dpi), the survival rate of rabbits fed B. subtilis was 
79.2, 57.8, and 50.6%, respectively, which were higher than the 
control group (P < 0.05; Figure 7A).
E. coli content in E. coli-infected rabbits
As shown in Figure 7B, the number of E. coli in the heart and 
cecal contents in the B. subtilis group were declined compared to 
controls at 1 dpi. At 3 dpi, the number of E. coli in all tested tissues 
declined compared to those of 1 dpi. In particular, rabbits fed with 
the diet of B. subtilis had lower (P < 0.05) E. coli content in their 
cecal contents compared to the controls at 3 dpi.
expression of innate immune-related 
genes in the spleen and Jejunum of the 
infected rabbits
As shown in Figure 8, the expression of all innate immune-related 
genes was not as obvious as in the spleen and jejunum at 1 dpi. 
However, the expression of NOD2, NLRC3, and NLRX1 in the 
jejunum was significantly upregulated at 3 dpi. The expression of 
NLRC3, in particular, was upregulated by 18.18-fold (P < 0.05; 
Figure 8C), whereas the expression of NOD1 increased by 4.63-
fold in the spleen (P < 0.05; Figure 8A). Similarly, the expression 
of IL-1β, IL-4, IL-8, and IFN-γ in the spleen and jejunum showed 
upregulating tendencies, but to a greater extent. At 3  dpi, the 
expression of IFN-γ increased 251.41-fold (P < 0.05; Figure 8E). 
Furthermore, the expression level of β-defensin was generally 
higher in the spleen than in the jejunum at 3 dpi. DEFB 124,DEFB 
125,DEFB 127, and DEFB 128 showed a relatively low expression 
compared with DEF114 and DEFB134, with a fold change between 
twofold and eightfold in the spleen or the jejunum. At 3 dpi, the 
expressions of DEFB 114 and DEFB 134 were upregulated and 
reached 78.93- and 25.89-fold (P < 0.05; Figures 8J,O). However, 
in the jejunum, the expression of DEFB 135 was upregulated by 
65.69-fold at 3 dpi (P < 0.05; Figure 8P).
DiscUssiOn
To influence the gastrointestinal tract, probiotics should also be 
excellent in adapting to acidic conditions in the stomach and 
in bile salt in the duodenum. Hydrochloric acid in gastric juice 
can kill bacteria in food to ensure the safety of the stomach and 
intestines and activate pepsin for digestion. It has also been 
reported that good bile tolerance benefits colonization in the 
host’s gastrointestinal tract (25). Maintaining a high survival 
rate in acid and bile salt tolerance tests means that an effective 
number of live bacteria will enter the intestinal tracts and suc-
cessfully play a role. After overnight incubation, the Bacillus 
cultures were examined microscopically, and no more than 5% 
of free spores were observed. Therefore, the remarkable resist-
ance of five B. subtilis strains to gastric intestinal juice and bile 
FigUre 5 | The expression of immune-related genes in the spleen and jejunum of rabbits after 5 and 7 weeks of feeding. (a) NOD1, (b) NOD2, (c) 
NLRC3, (D) NLRX1, (e) IFN-γ, (F) IL-1β, (g) IL-4, (h) IL-8, (i) IL-10, (J) OAS, (K) PKR, (l) DEFB114, (M) DEFB124, (n) DEFB125, (O) DEFB127, (P) DEFB128, (Q) 
DEFB134, (r) DEFB135, and (s) NP5. The fold change represents gene expression in diet with Bacillus subtilis compared to that of the controls. Bars represented 
the means ± SDs of three independent experiments (five rabbits per experiment). Mann–Whitney U test was conducted to examine differences. *P < 0.05.
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FigUre 7 | rabbits fed with the diet of 0 and 106 cFU g−1 Bacillus subtilis were inoculated intraperitoneally with 1.5 ml of enterohemorrhagic 
Escherichia coli bacterial suspension (108 cFU ml−1) after 7 weeks of feeding. (a) The survival rate of rabbits after infection with E. coli: control and rabbits 
fed with the diet of 106 CFU g−1 B. subtilis (n = 14). (b) E. coli content of infected rabbits at 1 and 3 dpi (log10 CFU g−1). Bars represented the means ± SDs of three 
independent experiments (five rabbits per experiment). Mann–Whitney U test was conducted to examine differences. *P < 0.05.
FigUre 6 | rabbit kidney (rK-13) cells were cocultured with live 
Bacillus subtilis or killed cells in DMeM without antibiotic for 2 h at 
37°c. The medium was removed, and cells were washed three times with 
PBS containing 1% penicillin–streptomycin solution to kill B. subtilis. RK-13 
cells were cultured in DMEM containing 1% penicillin–streptomycin solution 
for 24 h. Also, 100 μl of the DMEM were plated onto nutrient agar to ensure 
effective killing of B. subtilis. The fold change represents gene expression of 
RK-13 cells stimulated with live B. subtilis and killed cells compared to that of 
controls. Bars represented the means ± SDs of three independent 
experiments. Mann–Whitney U test was conducted to examine differences. 
*P < 0.05.
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salt conditions can not be due to the presence of spores. Bacillus 
sp. can produce certain essential nutrients and extracellular 
enzymes, as well as provide necessary growth factors to promote 
host growth (5). BG5 and BGY12 had good performance in the 
protease activities. BYS2, BQ3, and BD17 appeared to inhibit 
pathogenic bacteria, and, of course, all five strains showed no 
antibiotic resistance. On the other hand, strain that does not 
have any probiotic activity or killed cells can not produce diges-
tive enzymes, vitamins, and antibacterial substances, which were 
produced by probiotic. Based on these reasons, we speculated 
that strains without probiotic activity and killed cells have no 
significant effects on growth performance, intestinal flora and 
disease resistance.
In poultry and pigs, B. subtilis (1.8 × 106 CFU g−1 diet) pro-
moted animal growth and immune regulation (18, 26) and can 
also help animals resist intestinal pathogenic bacteria infection 
(27). In a similar study, Bacillus circulans (2 × 106 CFU g−1 diet) 
significantly enhanced the growth performance and non-specific 
immunity levels and disease resistance of fish (28). In the present 
study, rabbits fed with a diet containing B. subtilis at 106 CFU g−1 
had significantly improved average weight gain, which might 
result from the production of nutrients and digestive enzymes. 
Rabbits fed a diet of 107  CFU  g−1 B. subtilis did not grow as 
well as those fed with 106  CFU  g−1, perhaps because nutrients 
in the gut of rabbits was absorbed by the addition of B. subtilis. 
In previous research, there was no difference between the group 
supplemented with B. subtilis alone and the controls (29). Such 
discrepancies could stem from differences among experimental 
conditions or among species of probiotics.
In this study, dairy with B. subtilis significantly improved 
concentrations of the serum immunoglobulins IgG and IgA of 
rabbits. Moreover, the relative weights of the spleen were sig-
nificantly increased by dietary supplementation with B. subtilis 
after 5 weeks of feeding. It can thus be deduced that B. subtilis 
might improve immune function, which has been reported to 
reduce weaning stress and improve the growth performance of 
rabbits at weaning (30). It has been reported that Bacillus cereus 
increased the concentrations of beneficial bacteria and decreased 
the concentration of harmful bacteria (31). In the current 
study, the relative abundance of Bacteroides and Clostridium 
were significantly decreased, and Ruminococcus increased after 
feeding B. subtilis. The Ruminococcus contributed to the diges-
tion and absorption of fiber in herbivores (32). The increase of 
Ruminococcus may promote the growth performance of rabbits. 
In addition, the increase of Bacteroides and Clostridium in the 
intestine leads to colitis and carcinogenesis (33). These findings 
indicate that dairy with B. subtilis can regulate intestinal flora and 
maintain intestinal health.
The innate immune system is used as the first line of defense to 
various pathogens. NLRs are a kind of pattern recognition recep-
tor (PRR). PRRs have been implicated in pathogen control and 
elimination and have been recently identified as key mediators 
of inflammatory and immune responses. There are few reports 
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FigUre 8 | The expression of immune-related genes in the spleen and jejunum of rabbits at 1 and 3 dpi. (a) NOD1, (b) NOD2, (c) NLRC3, (D) NLRX1, 
(e) IFN-γ, (F) IL-1β, (g) IL-4, (h) IL-8, (i) IL-10, (J) DEFB114, (K) DEFB124, (l) DEFB125, (M) DEFB127, (n) DEFB128, (O) DEFB134, (P) DEFB135, and (Q) NP5. 
The fold change represents gene expression in diet including Bacillus subtilis compared to that of controls. Bars represented the means ± SDs of three independent 
experiments (five rabbits per experiment). Mann–Whitney U test was conducted to examine differences. *P < 0.05.
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about NLRs in rabbits, and only the predicted sequences are 
available in Genebank. At present, the full lengths of some NLRs 
in rabbits have been obtained, and their biological functions 
(no published data) have been verified. In this study, the dietary 
administration of B. subtilis increased the NOD1, NLRC3, and 
NLRX1. NLRs detect and sense microbial components and then 
lead to the activation of an inflammatory response and promote 
the secretion of cytokines (34, 35). A previous study has shown 
that NLRCs induce IFN-γ and IL-1β gene expression in Japanese 
flounder (36). Olive flounder NOD1 not only plays a major role 
in inhibition of Edwardsiella tarda growth but also enhances the 
activation of IL-1β, which is in turn implicated in the initiation 
of inflammation and host defense (37). IL-1β is a major proin-
flammatory cytokine that induces its own expression as well as 
the expression of other proinflammatory cytokines, adhesion 
molecules, and chemokines such as IL-6, IL-8, and TNF-α, in 
turn initiating an inflammatory response and recruitment of 
antimicrobial cells such as neutrophils and macrophages (38). 
The main biological activity of IFN-γ is immune regulation, 
which includes innate and adaptive immunity. In previous 
studies, pretreatment with B. subtilis, the IFN-γ transcript levels 
remained high after infection with Citrobacter rodentium (39, 
40). It has been shown to be a proinflammatory factor and has 
an antiviral effect (41). In this study, IFN-γ, IL-1β, and IL-8 were 
upregulated by dietary B. subtilis. It may be due to the activation 
of NLRs.
Previous studies have suggested that several probiotics induce 
innate immunity through β-defensin 2 induction in Caco-2 cells 
(42). The antimicrobial peptide (AMP) is a class of molecules 
that occurs in all forms of life, from multicellular organisms to 
bacterial cells. In higher organisms, AMPs contribute to innate 
immunity and are part of the first line of defense against various 
microorganisms, including Gram-positive and Gram-negative 
bacteria, fungi, and viruses (43). The defensins are small, 
cationic, cystine-rich AMPs with broad antimicrobial activities. 
They can recruit immature dendritic cells and macrophages to 
reach the skin and mucosal tissues of microbial invasion through 
chemokine receptors, thus inducing specific immunity of patho-
genic bacteria. In mammals, defensins are divided into α-, β-, 
and θ-defensins (44). The results of the present study suggest 
that the α-defensin and β-defensin were induced by a diet with B. 
subtilis. On the one hand, defensins can directly act on pathogenic 
microorganisms and more importantly participate in the innate 
immunity as well as the initiation and regulation of adaptive 
immune response. Previous study has demonstrated that lacto-
bacilli and the VSL#3 bacterial mixture restored intestinal barrier 
function through the upregulation of human-beta defensin 2 via 
induction of proinflammatory pathways of the nuclear factor-κB 
(45). However, the genomic structure and PGN of bacteria also 
exist in the killed cells. They can be identified by the host PRRs, 
which trigger the innate immune response. So killed cells are 
able to induce a certain degree of protective immune responses. 
Our results indicated that live Bacillus showed stronger ability 
in induce innate immunity than the killed cells when used the 
same dose in the RK-13 cells. To the best of our knowledge, this 
research is the first report on the innate immune response to B. 
subtilis in rabbits.
In return, the survival rate of rabbits fed B. subtilis was 
higher than that of the controls after they were challenged 
with E. coli. This conclusion was supported by increased body 
weights, serum immunoglobulin, and immune organ index and 
enhanced expression of major innate immunity genes involved 
in initiating and regulating immune response against E. coli. It 
is worth noting that β-defensin was significantly upregulated in 
the B. subtilis feeding group postinfection with E. coli, especially 
DEFB 114, DEFB 134, and DEFB 135. Given that β-defensin has 
a strong antibacterial ability, the higher expression of β-defensin 
may be the most important reason for disease resistance. 
Meanwhile, the present results showed that the number of E. 
coli in the cecal contents significantly declined with a diet of 
B. subtilis during the test days. As various reports have shown, 
several bacilli have established antimicrobial properties against 
various Gram-positive and Gram-negative pathogenic bacteria 
(46). In this study, BYS2, BQ3, and BD17 have also shown strong 
inhibition against E. coli in  vitro and therefore possess potent 
immunostimulatory capacities. It is also important that the 
intestinal flora is mainly composed of anaerobic bacteria, and 
relatively few aerobic bacteria. B. subtilis can inhibit the growth 
of pathogenic E. coli by consuming oxygen in the intestine and 
regulating the balance of intestinal flora. Previous research 
showed that B. subtilis PY79hr can inhibit colonization and per-
sistence of Salmonella enteritidis, C. perfringens, and E. coli (47). 
In the intestine, B. subtilis may prevent the overgrowth of E. coli, 
enhance the resistance to E. coli invasion of the intestinal tract, 
and ameliorate disease processes. As a result, a diet including B. 
subtilis decreased the concentration of E. coli in vivo. B. subtilis 
may be competitive exclusion approaches in the control of infec-
tion with enteric pathogens.
In conclusion, the five B. subtilis that were selected for 
in vitro experiment showed good probiotic potential in rabbits. 
Enhancing the disease resistance of rabbits fed with B. subtilis 
may due to the probiotic’s influence on the improved growth 
performance, serum immunoglobulin, immune organ index, 
intestinal homeostasis, and immune response of rabbits, as well 
as its antibacterial benefits. The data from this study enhance the 
understanding of the mechanism of action between probiotics 
and the host, allowing for the development of probiotic-based 
strategies to prevent pathogenic infection.
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